Comparison of 2 drug combinations for sedation in cervical cancer patients undergoing radiotherapy
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/03/063806
- Lead Sponsor
- Ananta institute of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of cervical cancer scheduled for elective
brachytherapy
Patients aged between 20-70 years
ASA I, II
Exclusion Criteria
History of cardiovascular diseases e.g. ischaemic heart disease,conduction defects, etc.
History of compromised renal / hepatic / neuronal functions.
Uncontrolled hypertension and Diabetes
Pregnant or lactating women.
History alcohol, substance abuse, chronic use of analgesic and
sedatives, psychiatric disorders
Patients on b blocker or having persistent bradycardia with HR30
min
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Onset and recovery of sedationTimepoint: Baseline, 1,2,5,7,10,15,20,25 and 30 minutes.
- Secondary Outcome Measures
Name Time Method Intraoperative Haemodynamics (Heart <br/ ><br>Rate,Blood Pressure, Spo2, Respiratory rate) <br/ ><br>Post op recovery score (Modified Aldrete Score) <br/ ><br>Duration of analgesiaTimepoint: Baseline, 1, 2,5,7,10,15,20,25 & 30 minutes & then hourly for 6 hours.